功效：提高体内免疫系统的防御功能，促进免疫细胞增长，激发免疫细胞活性，清除怖内自由基和病菌病毒，当人体出现坏死细胞，变异细胞以至肿瘤细胞时，能够靶向清除并排除体外。从而提高机体抗病能力和生命力！
n. inhibitor
misc. inhibiting factor
... inhibiting factor 抑制因子 inhibiting factors 抑制因子 inhibiting principle of chemical reaction 化学反应的抑制原理 ...
基于176个网页-相关网页
...位的艾灸，可明显提高老年人红细胞(C3b)受体活性，增强红细胞清除免疫复合物的能力，并能拮抗血清中红细胞免疫粘附抑制因子(RFIR)，增强红细胞免疫功能，同时还能调整机体的内环境，增强机体清除自由基的能力。
基于98个网页-相关网页
... 抑制因子 suppressor 肾上腺 suprarenal gland， adrenal (gland) 肾上腺素 suprarenin， adrenalin(e)， epinephrine ...
基于92个网页-相关网页
巨噬细胞移动抑制因子 MIF ; macrophage migration inhibitory factor ; macrophage ; macrophage migration inhibitor
白血病抑制因子 LIF ; leukemia inhibitory factor ; Human Leukemia inhibitory factor ; leuki inhibitory fctor
交换抑制因子 [遗] crossover suppressor ; crossing over suppressor ; crossover repressor
人白血病抑制因子 LIF ; Human LIF ; human leukemia inhibitory factor
白血病抑制因子受体 LIFR
纤溶抑制因子 TAFI
白细胞蛋白酶抑制因子 SLPI ; secretory leukocyte protease inhibitor
组织抑制因子 tissue inhibitor of metalloproteinase ; TIMP ; tissue inhibitor of matrix metalloproteinases
胰蛋白酶抑制因子 trypsin ihhibitor ; TI ; KTI ; trypsin inhibitor-like
Tumor suppressor p53 plays an important role in mediating apoptosis and cell cycle capture in response to different stress including virus infection, and regulating host antiviral defense is new function of p53.
肿瘤抑制因子p53在细胞中具有细胞周期捕获、诱导细胞凋亡和抗病毒等功能。
参考来源 - 猪流感病毒感染细胞内p53活性变化机制解析It introduces hold-down factor, which is an additional terminal condition for expanding nodes, besides traditional one. For generating node, if the hold-down factor of some sample is bigger than the given threshold, the node will not be expanded any more.
对即将扩张的结点,除了常用的终止条件外,再加入一个终止条件:若样本的抑制因子大于给定的阈值,便不再扩展该结点。
参考来源 - 一种新的基于粗糙集模型的决策树算法·2,447,543篇论文数据，部分数据来源于NoteExpress
抑制因子的整体结构与阻遏物蛋白的相比变化不大。
The overall structure of the repressor is little changed from that of the aporepressor.
目的探讨巨噬细胞移动抑制因子在脓毒症小鼠心脏和肾组织中的表达规律。
Objective to investigate the expression profile of macrophage inhibitory factor in heart and renal tissues of sepsis mice.
但这些称为EGFR抑制因子如西妥昔单抗的药物对结肠癌的治疗还不是很有效。
But these drugs called EGFR inhibitors, such as cetuximab, have not been very effective against colon cancer.
应用推荐